BRICANYL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bricanyl, and when can generic versions of Bricanyl launch?
Bricanyl is a drug marketed by Sanofi Aventis Us and is included in three NDAs.
The generic ingredient in BRICANYL is terbutaline sulfate. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bricanyl
A generic version of BRICANYL was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.
Summary for BRICANYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 9 |
Patent Applications: | 4,146 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BRICANYL at DailyMed |
Recent Clinical Trials for BRICANYL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Monastir | Phase 1 |
Yaakov Beilin | Phase 2/Phase 3 |
University of Monastir | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for BRICANYL
US Patents and Regulatory Information for BRICANYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018000-001 | Mar 19, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | INJECTABLE;INJECTION | 017466-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRICANYL
International Patents for BRICANYL
See the table below for patents covering BRICANYL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 151693 | ⤷ Try a Trial | |
Spain | 361429 | ⤷ Try a Trial | |
Finland | 50788 | ⤷ Try a Trial | |
Spain | 346131 | ⤷ Try a Trial | |
Spain | 361431 | ⤷ Try a Trial | |
Norway | 124723 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |